Q4 2023 Holdings
Filed 2024-02-13 | 5 holdings | $197.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Pharvaris N.V.(PHVS) | COM | N69605108 | $113.3M | 4,038,842 | 57.3% |
| Kura Oncology, Inc.(KURA) | COM | 50127T109 | $26.6M | 1,849,947 | 13.4% |
| Kinnate Biopharma Inc. | COM | 49705R105 | $22.9M | 9,671,643 | 11.6% |
| Syndax Pharmaceuticals, Inc.(SNDX) | COM | 87164F105 | $18.9M | 875,000 | 9.6% |
| Lyell Immunopharma, Inc. | COM | 55083R104 | $16.2M | 8,325,000 | 8.2% |